Litcius/Paper detail

Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency

Suhail Khoja, Xiao-Bo Liu, Brian Truong, Matthew Nitzahn, Jenna Lambert, Adam Eliav, Eram Nasser, Emma Randolph, Kristine Burke, Rebecca White, Xuling Zhu, Paolo G.V. Martini, Itzhak Nissim, Stephen D. Cederbaum, Gerald S. Lipshutz

2022Molecular Therapy — Nucleic Acids26 citationsDOIOpen Access PDF

Abstract

mRNA administration in arginase deficiency prevents the associated leukodystrophy and restores normal oligodendrocyte function.

Topics & Concepts

ArginaseMyelinOligodendrocyteEndocrinologyInternal medicineLeukodystrophyBiologyCentral nervous systemChemistryMedicineBiochemistryAmino acidDiseaseArginineMetabolism and Genetic DisordersNeurogenetic and Muscular Disorders ResearchAmino Acid Enzymes and Metabolism
Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency | Litcius